Instituto de Investigación Biomédica de A Coruña (INIBIC)
Centro de investigación
Pfizer (United States)
Nueva York, Estados UnidosPublicacións en colaboración con investigadores/as de Pfizer (United States) (29)
2024
-
Effect of long-term tafamidis treatment on health-related quality of life in patients with transthyretin amyloid cardiomyopathy
European Journal of Heart Failure
2023
-
Efficacy of Lorlatinib in Treatment-Naive Patients With ALK-Positive Advanced NSCLC in Relation to EML4::ALK Variant Type and ALK With or Without TP53 Mutations
Journal of Thoracic Oncology, Vol. 18, Núm. 11, pp. 1581-1593
-
Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK, an Open-Label Phase IV Trial
Journal of Rheumatology, Vol. 50, Núm. 4, pp. 478-487
2022
-
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study
European Journal of Cancer, Vol. 168, pp. 12-24
-
Response to: 'Use of tanezumab for patients with hip and knee osteoarthritis with reference to a randomised clinical trial by Berenbaum and colleagues' by Riddle and Perera
Annals of the Rheumatic Diseases
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor–positive metastatic breast cancer: Patient-reported outcomes in the PEARL study
European Journal of Cancer, Vol. 156, pp. 70-82
-
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
The Lancet Oncology, Vol. 22, Núm. 2, pp. 212-222
-
Patient Journey in Atopic Dermatitis: The Real-World Scenario
Dermatology and Therapy, Vol. 11, Núm. 5, pp. 1693-1705
-
Subcutaneous tanezumab for osteoarthritis: Is the early improvement in pain and function meaningful and sustained?
European Journal of Pain (United Kingdom), Vol. 25, Núm. 7, pp. 1525-1539
2020
-
Cost-effectiveness analysis of second-line pharmacological treatment of acromegaly in Spain
Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 20, Núm. 1, pp. 105-114
-
Gaps between research and recommendations in rheumatoid arthritis
Rheumatology International
-
Gender differences in health-related quality of life in patients with systolic heart failure: Results of the vida multicenter study
Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-15
-
Subcutaneous tanezumab for osteoarthritis of the hip or knee: Efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period
Annals of the Rheumatic Diseases, Vol. 79, Núm. 6, pp. 800-810
2019
-
Development and validation of a sexual relations satisfaction scale in patients with breast cancer - "sEXSAT-Q"
Health and Quality of Life Outcomes, Vol. 17, Núm. 1
-
Treatment adherence to pegvisomant in patients with acromegaly in Spain: PEGASO study
Pituitary, Vol. 22, Núm. 2, pp. 137-145
2016
-
Cellular and molecular mechanisms of low cardiac output syndrome after pediatric cardiac surgery
Current Vascular Pharmacology, Vol. 14, Núm. 1, pp. 5-13
-
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356
Autophagy
-
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy, Vol. 12, Núm. 1, pp. 1-222
2014
-
Assessment of osteoarthritis candidate genes in a meta-analysis of nine genome-wide association studies
Arthritis and Rheumatology, Vol. 66, Núm. 4, pp. 940-949